Hims & Hers Health, Inc.
$1.11B- Market cap
- $0.00
- Debt
- +$1.34B
- Cash
- −$228.62M
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt cap
Decision snapshot: HIMS stock price vs QRVO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at QRVO's multiple
Needs QRVO P/E.
Implied fair value · at HIMS's multiple
Needs HIMS P/E.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIMS FY 2025 (ended Dec 31, 2025) · QRVO FY 2026 (ended Mar 28, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 0% equity / 100% debt · EV / Revenue 0.47x · EV / EBITDA 7.55x
Capital structure 85% equity / 15% debt · EV / Revenue 2.55x · EV / EBITDA 11.63x
QRVO carries the larger enterprise value at $9.38B against $1.11B; HIMS trades on the lower EV / Revenue multiple (0.47x vs 2.55x); HIMS on the lower EV / EBITDA (7.55x vs 11.63x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Qorvo, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.48x
0.46x
Net debt / EBITDA
Leverage against operating earnings
7.55x
0.41x
Cash and equivalents
Liquid reserves on the balance sheet
$228.62M
$1.22B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Teladoc Health, Inc.
HIMS vs TDOC
GoodRx Holdings, Inc.
HIMS vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
HIMS vs CLOV
Roivant Sciences Ltd.
HIMS vs ROIV
SKYWORKS SOLUTIONS, INC.
HIMS vs SWKS
Broadcom Inc.
HIMS vs AVGO
Marvell Technology, Inc.
HIMS vs MRVL
ON SEMICONDUCTOR CORP
HIMS vs ON
NXP Semiconductors N.V.
HIMS vs NXPI
TEXAS INSTRUMENTS INC
HIMS vs TXN
$1.34B
$1.55B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.